Synopsis of recent research by authors named "Chun-Yong Wen"
- Chun-Yong Wen's research primarily focuses on innovative approaches in the treatment and management of liver cancer, particularly through techniques such as hepatic arterial infusion chemotherapy (HAIC) and transarterial chemoembolization (TACE).
- A comparative study demonstrated that transradial access (TRA) may be a safer and more patient-friendly option than transfemoral access (TFA) for delivering HAIC in patients with liver cancer.
- Additionally, findings revealed that microRNA-375 plays a significant role in inhibiting the malignant behaviors of hepatic carcinoma cells, highlighting it as a potential therapeutic target, while the prognostic value of splenic volume in HCC patients undergoing TACE offers insights into survival determinants for better clinical outcomes.
